Who is the Director of NIPER Raebareli, quoted on the proposed Centre of Excellence?
- A.Manoj Joshi
- B.Dr Shubhini Saraf
- C.Praveen Rao Akkinepally
- D.Dr M L Jat
Correct answer
Explanation
The correct answer is Dr Shubhini Saraf. As Director of NIPER Raebareli she said the proposed Centre of Excellence would serve as a dedicated platform for structured training and certification in clinical research, and that bringing academic and industry expertise together would produce a model capable of being repeated in other regions and therapeutic areas. Option A, Manoj Joshi, is the Secretary of the Department of Pharmaceuticals, in whose presence the memorandum was signed, and he spoke about widening the pool of skilled professionals outside the metros. Option C, Praveen Rao Akkinepally, is Country President and Managing Director of AstraZeneca Pharma India Limited and spoke of expanding trial participation. Option D is unrelated to this agreement. Keeping the three names and their exact designations apart is the usual trap in questions built on such a signing.
Read the full article: NIPER Raebareli, AstraZeneca Tie Up for 25 Trial Sites
Practice Questions
How many clinical trial sites will be adopted under the NIPER Raebareli and AstraZeneca India collaboration?
- A.10
- B.25
- C.50
- D.100
Show answer
The partnership begins by adopting 25 clinical trial sites in emerging research geographies, assessing what each can do, and then giving the staff targeted training and mentoring while tightening documentation and the processes around ethics, safety and trial feasibility.
Read the full explanation →The clinical research collaboration signed at New Delhi advances which flagship government initiative?
- A.Biopharma SHAKTI
- B.Ayushman Bharat
- C.Mission Indradhanush
- D.PRIP Scheme
Show answer
It is described as the central government's flagship initiative for building a stronger biopharma ecosystem, and among its goals is the creation of a thousand clinical trial sites across the country; the partnership between NIPER Raebareli and AstraZeneca India directly serves that objective.
Read the full explanation →Which body signed the YETI development agreement with ideaForge Technology Limited?
- A.Defence Research and Development Organisation
- B.Technology Development Board
- C.Indian Space Research Organisation
- D.Council of Scientific and Industrial Research
Show answer
The TDB works under the Department of Science and Technology and it is the body that signed the agreement with ideaForge Technology Limited of Mumbai for support under the Research Development and Innovation Fund.
Read the full explanation →Up to what altitude above mean sea level is YETI designed to operate?
- A.4,500 metres
- B.5,500 metres
- C.6,500 metres
- D.8,500 metres
Show answer
YETI is designed for an operating altitude of up to 6,500 metres above mean sea level, which is what allows it to be considered for high-altitude work in the mountains, and its weather-resistant build is also meant for deserts and marine conditions.
Read the full explanation →What is the maximum payload YETI is designed to carry?
- A.50 kg
- B.100 kg
- C.200 kg
- D.500 kg
Show answer
YETI is designed to lift payloads of up to 200 kg, and by a neat coincidence the same figure is its targeted range in kilometres, which makes the pair easy to remember together.
Read the full explanation →